Skip to main content

Table 2 Serum cytokine profiles in two disease types of Mycobacterium avium complex lung disease

From: Multiplex cytokine analysis in Mycobacterium avium complex lung disease: relationship between CXCL10 and poor prognostic factors

Cytokine/GF protein (pg/mL)

Radiographic Features

*P-value

 

min LOD

max LOD

FC (N = 6)

NS (N = 21)

 

Proinflamatory

G-CSF

16

10,000

46.6 (32.4–68.4)

N/A

< 0.05

GM-CSF

0.64

10,000

11.4 (1.8–50.1)

3.5 (0.64–11.7)

NS

IFN-γ

3.2

10,000

12.8 (6.2–37.6)

3.9 (3.2–29.7)

NS

IL-1β

0.64

10,000

3.0 (0.64–20.6)

N/A

NS

IL-6

0.64

2000

38.6 (18.1–225.3)

21.7 (3.8–87.6)

NS

IL-7

0.64

2000

13.1 (6.3–32.5)

6.5 (0.64–9.0)

NS

IL-17A

0.64

10,000

3.1 (1.2–9.0)

1.7 (0.3–15.6)

NS

sCD40L

0.64

10,000

N/A

5278 (3960–6276)

< 0.05

TNF-α

0.64

10,000

50.6 (19.3–131.3)

45.2 (25.6–73.5)

NS

Chemokine

Eotaxin

3.2

10,000

122 (101–134)

134 (112–168)

NS

GRO

16

10,000

1285 (1137–1784)

896 (771–1567)

NS

IL-8

0.64

10,000

361 (143–906)

230 (104–650)

NS

CXCL10

3.2

10,000

979 (757–1496)

451 (268–556)

< 0.05

CCL2

3.2

10,000

600 ± 120

600 ± 183

NS

CCL3

16

2000

345 (14–610)

216 (124–505)

NS

CCL4

16

10,000

191 (37–415)

173 (93–373)

NS

CCL22

16

10,000

863 ± 163

657 ± 309

NS

Anti-inflammatory

IL-1RA

3.2

10,000

73.9 (31.3–136.5)

18.7 (3.2–29.4)

< 0.005

IL-5

0.64

10,000

1.9 (0.64–5.9)

N/A

NS

IL-10

0.64

10,000

3.5 (1.4–14.7)

N/A

< 0.05

Growth factor

EGF

16

10,000

294 ± 66

247 ± 117

NS

FGF-2

16

10,000

94.3 (48.9–150.9)

55.0 (16.3–82.3)

NS

Flt-3 L

3.2

10,000

3.2 (3.2–21.7)

12.1 (3.2–27.4)

NS

TGF-α

0.64

2000

12.0 (10.3–18.9)

6.6 (4.6–13.0)

NS

VEGF

80

10,000

531 ± 318

300 ± 234

NS

  1. Data are presented as mean ± standard deviation, or median (interquartile range). Items with more than half cases below or over the LOD were excluded
  2. Abbreviations, GF growth factor, LOD limit of detection, FC fibrocavitary type, NB nodular bronchiectatic type, EGF epidermal growth factor, FGF fibroblast growth factor, Flt-3 L FMS-like tyrosine kinase 3 ligand, G-CSF granulocyte colony-stimulating factor, GM-CSF granulocyte macrophage-CSF, GRO growth-related oncogene, IFN-γ interferon gamma, IL interleukin, IL-1RA IL-1 receptor antagonist, CXCL10 CXC motif ligand 10, CCL CC motif ligand, sCD40L soluble CD40 ligand, TGF transforming growth factor, TNF tumor necrosis factor, VEGF vascular endothelial growth factor, N/A not available (median was below or over LOD)
  3. *P-values were calculated in relation to two radiographic features. Student’s t-test or the Wilcoxon rank sum test was used. For enrolled cytokines/growth factors, we replaced the values less than LOD with LOD and analyzed with nonparametric analysis or Fisher’s exact test with cut-off as LOD value. NS, not significant